Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Nuwellis, Inc. (NUWE)

5.68 -0.10 (-1.73%)
At close: October 30 at 4:00:00 PM EDT
5.42 -0.26 (-4.58%)
Pre-Market: 7:50:56 AM EST
Chart Range Bar
Loading chart for NUWE
  • Previous Close 5.78
  • Open 5.59
  • Bid 5.11 x 100
  • Ask 5.60 x 100
  • Day's Range 5.20 - 6.10
  • 52 Week Range 2.52 - 1,556.10
  • Volume 4,659
  • Avg. Volume 891,781
  • Market Cap (intraday) 2.302M
  • Beta (5Y Monthly) 0.02
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 3,923.28
  • Earnings Date (est.) Nov 11, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

www.nuwellis.com

38

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NUWE
90.67%
S&P 500 (^GSPC)
10.73%

1-Year Return

NUWE
95.73%
S&P 500 (^GSPC)
11.11%

3-Year Return

NUWE
99.99%
S&P 500 (^GSPC)
81.91%

5-Year Return

NUWE
100.00%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 2.42M
Earnings -2.42M
Profit Margin -99.88%

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

-10M
-5M
0
-150.0%
-100.0%
-50.0%
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -125.63%

  • Return on Assets (ttm)

    -87.83%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    9.01M

  • Net Income Avi to Common (ttm)

    -11.32M

  • Diluted EPS (ttm)

    3,923.28

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.92M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -11.44M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: